LAG3 and neoplasm: The coexpression of PD-1 and LAG-3 is observed in tumor-infiltrating lymphocytes and contributes to T-cell exhaustion; coinhibition of PD-1 and LAG-3 showed synergistic response in preclinical models [47,48].